HP
56
4
CNX
46
-3
NWSA
58
-2
PRU
33
-4
GWW
39
-5
SRE
18
-19
AMAT
44
-4
NEE
34
-7
FCX
40
-3
DNB
60
-8
ADP
62
-4
CMG
54
-3
FOX
70
-7
EXR
22
-15
EQIX
57
-2
PEG
53
-4
PLD
32
-3
MLM
29
-3
EXPD
20
-3
MS
62
-7
HP
56
4
CNX
46
-3
NWSA
58
-2
PRU
33
-4
GWW
39
-5
SRE
18
-19
AMAT
44
-4
NEE
34
-7
FCX
40
-3
DNB
60
-8
ADP
62
-4
CMG
54
-3
FOX
70
-7
EXR
22
-15
EQIX
57
-2
PEG
53
-4
PLD
32
-3
MLM
29
-3
EXPD
20
-3
MS
62
-7
Financhill
Back

ProShares Short FTSE China 50 Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
55

YXI
ProShares Short FTSE China 50

Last Price:
$14.52
Seasonality Move:
-2.17%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Buy
55
ProShares Short FTSE China 50 (YXI) is a Buy

Is ProShares Short FTSE China 50 a Buy, Sell or Hold?

  • The current ProShares Short FTSE China 50 [YXI] share price is $14.55. The Score for YXI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • YXI is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

YXI Stock Price Chart

What is ProShares Short FTSE China 50's stock price today?

  • The ProShares Short FTSE China 50 share price today is $14.55
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and YXI is experiencing buying pressure, which is a positive indicator for future bullish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

YXI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.05 Buy
Relative Strength Index (14 RSI): 62.54 Buy
Chaikin Money Flow: 15021 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (13.49 - 14.17) Buy
Bollinger Bands (100): (13.05 - 16.29) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

YXI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.96 Buy
20-day SMA: 13.8 Buy
50-day SMA: 13.9 Buy
200-day SMA: 16.04 Sell
8-day EMA: 14.04 Buy
20-day EMA: 13.91 Buy
50-day EMA: 14.05 Buy
200-day EMA: 15.67 Sell

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

ProShares Short FTSE China 50 Earnings Growth & YXI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

ProShares Short FTSE China 50 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):